28,933 resources
By Version
By Authority
By Realm
Start Prev Rows 6400 - 6600 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1259 | Substance Use Disorder Short Acting Medication | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1260 | Viloxazine | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1266 | Diabetic Retinopathy Severity Level | active | 2025-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1272 | Diabetes | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.1273 | Diabetes | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.195.11.1003 | Counseling for Nutrition | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.195.11.1004 | Counseling for Nutrition | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.195.12.1003 | Counseling for Nutrition | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1001 | Antibiotic Medications for Pharyngitis | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1078 | Nifedipine Medications | active | 2022-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1080 | Contraceptive Medications | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1109 | Meperidine Medications | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1129 | Desiccated Thyroid Medications | active | 2021-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1143 | Isotretinoin | active | 2022-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1167 | Dipyridamole Medications | active | 2021-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1205 | Leucovorin | active | 2023-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1211 | Aspirin and Other Antiplatelets | active | 2024-06 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1212 | DTaP Vaccine | active | 2024-11 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1214 | Hepatitis A Vaccine | active | 2018-03 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1216 | Hepatitis B Vaccine | active | 2025-04 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1220 | Child Influenza Vaccine | active | 2022-02 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1222 | Inactivated Polio Vaccine (IPV) | active | 2021-09 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1228 | Pneumococcal Conjugate Vaccine | active | 2023-11 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1232 | Rotavirus Vaccine (3 dose schedule) | active | 2018-03 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1234 | Varicella Zoster Vaccine (VZV) | active | 2017-05 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1235 | Measles, Mumps and Rubella (MMR) Vaccine | active | 2017-05 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1252 | Guanfacine Medications | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1255 | Megestrol Medications | active | 2021-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1256 | Meprobamate Medications | active | 2021-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1266 | Aromatase Inhibitors | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1267 | Glucocorticoids (oral only) | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1481 | Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1482 | Potentially Harmful Antiinfectives for Older Adults | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1517 | Dementia Medications | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1530 | Antidepressant Medication | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1532 | Potentially Harmful Antipsychotics for Older Adults | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1001 | Antibiotic Medications for Pharyngitis | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1080 | Contraceptive Medications | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1143 | Isotretinoin | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1170 | Varicella Zoster Vaccine (VZV) | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1205 | Leucovorin | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1211 | Aspirin and Other Antiplatelets | active | 2024-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1213 | Antidepressant Medication | active | 2021-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1214 | DTaP Vaccine | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1215 | Hepatitis A Vaccine | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1216 | Hepatitis B Vaccine | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1218 | Child Influenza Vaccine | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1219 | Inactivated Polio Vaccine (IPV) | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1221 | Pneumococcal Conjugate Vaccine | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1223 | Rotavirus Vaccine (3 dose schedule) | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1224 | Measles, Mumps and Rubella (MMR) Vaccine | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1265 | Aromatase Inhibitors | active | 2018-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1266 | Glucocorticoids (oral only) | active | 2018-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1480 | Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1481 | Potentially Harmful Antiinfectives for Older Adults | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1510 | Dementia Medications | active | 2019-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1522 | Potentially Harmful Benzodiazepines for Older Adults | active | 2022-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.12.1523 | Potentially Harmful Antipsychotics for Older Adults | active | 2022-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1005 | Bilateral Mastectomy | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1009 | Primary THA Procedure | active | 2023-07 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1015 | Flexible Sigmoidoscopy | active | 2023-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1016 | Flexible Sigmoidoscopy | active | 2017-12 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1017 | Flexible Sigmoidoscopy | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1020 | Fecal Occult Blood Test (FOBT) | active | 2017-12 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1023 | Group A Streptococcus Test | active | 2024-11 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1024 | HbA1c Laboratory Test | active | 2023-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1026 | Hysterectomy with No Residual Cervix | active | 2023-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1027 | Hysterectomy with No Residual Cervix | active | 2024-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1035 | Total Colectomy | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1036 | Total Colectomy | active | 2021-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1055 | XRay Study | active | 2022-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1061 | Gastric Bypass Surgery | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1062 | Gastric Bypass Surgery | active | 2018-03 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1080 | Primary THA Procedure | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1084 | History of bilateral mastectomy | active | 2017-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1085 | History of bilateral mastectomy | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1086 | Status Post Left Mastectomy | active | 2018-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1087 | Status Post Right Mastectomy | active | 2018-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1089 | Unilateral Mastectomy, Unspecified Laterality | active | 2017-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1090 | Unilateral Mastectomy, Unspecified Laterality | active | 2017-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1091 | Status Post Left Mastectomy | active | 2017-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1092 | Status Post Right Mastectomy | active | 2017-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1096 | Major Transplant | active | 2021-09 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1097 | Major Transplant | active | 2021-08 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1132 | Unilateral Mastectomy Left | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1133 | Unilateral Mastectomy Right | active | 2021-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1134 | Hysterectomy with No Residual Cervix | active | 2023-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1135 | Hysterectomy with No Residual Cervix | active | 2020-03 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1140 | Bilateral Mastectomy | active | 2019-03 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1143 | Total Colectomy | active | 2019-03 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1144 | Unilateral Mastectomy Left | active | 2019-03 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1145 | Unilateral Mastectomy Right | active | 2019-03 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.11.1148 | Palliative Intervention | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1005 | Bilateral Mastectomy | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1006 | Primary THA Procedure | active | 2023-08 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1010 | Flexible Sigmoidoscopy | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1011 | Fecal Occult Blood Test (FOBT) | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1012 | Group A Streptococcus Test | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1013 | HbA1c Laboratory Test | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1014 | Hysterectomy with No Residual Cervix | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1019 | Total Colectomy | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1034 | XRay Study | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1050 | Gastric Bypass Surgery | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1068 | History of bilateral mastectomy | active | 2017-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1069 | Status Post Left Mastectomy | active | 2017-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1070 | Status Post Right Mastectomy | active | 2017-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1071 | Unilateral Mastectomy, Unspecified Laterality | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1075 | Major Transplant | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1133 | Unilateral Mastectomy Left | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1134 | Unilateral Mastectomy Right | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.198.12.1135 | Palliative Care Intervention | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.199.11.1064 | Anaphylactic Reaction to DTaP Vaccine | active | 2022-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.199.11.1100 | Malabsorption Syndromes | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.199.11.1102 | Malabsorption Syndromes | active | 2022-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.199.11.1105 | Intussusception | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.199.11.1106 | Intussusception | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.199.11.1107 | Influenza Virus LAIV Vaccine | active | 2021-02 | us | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.199.11.1108 | Influenza Virus LAIV Vaccine Administered | active | 2021-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.199.12.1031 | Anaphylactic Reaction to DTaP Vaccine | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.199.12.1050 | Malabsorption Syndromes | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.199.12.1056 | Intussusception | active | 2017-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1004.2446 | Lower Extremity Visual Inspection Test | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1004.2447 | Pedal Pulse Result or Finding | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1004.2448 | Monofilament Test Result or Finding | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1004.2449 | Monofilament Tests | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1004.2450 | Lower Extremity Neurological Assessment Result or Finding | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1004.2451 | Lower Extremity Neurological Tests | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1004.2452 | Lower Extremity Visual Inspection Result or Finding | active | 2023-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1004.2616 | Autonomous Eye Exam Result or Finding | active | 2025-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.1577 | Pharmacologic Therapy for Hypertension | active | 2021-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1036 | Chronic Kidney Disease, Stage 5 | active | 2017-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1037 | Chronic Kidney Disease, Stage 5 | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1049 | Patient Provider Interaction | active | 2020-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1058 | Psych Visit for Family Psychotherapy | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1063 | Occupational Therapy Evaluation | active | 2017-08 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1067 | Dementia and Mental Degenerations | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1068 | Dementia and Mental Degenerations | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1069 | Standardized Tools for Assessment of Cognition | active | 2017-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1071 | Radiation Treatment Management | active | 2017-08 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1072 | Radiation Treatment Management | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1073 | Standardized Pain Assessment Tool | active | 2017-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1078 | Cancer | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1079 | Cancer | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1080 | Chemotherapy Administration | active | 2024-01 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1081 | Chemotherapy Administration | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.111 | Ophthalmological Services | active | 2021-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.113 | Prostate Cancer Treatment | active | 2025-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.118 | Initial Myocardial Infarction | active | 2020-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.119 | Initial Myocardial Infarction | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.120 | Coronary Artery Disease No MI | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1238 | Ejection Fraction | active | 2025-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1243 | Psychoanalysis | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1244 | Renal Failure Due to ACE Inhibitor | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1251 | Group Psychotherapy | active | 2017-05 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1256 | Allergy to ACE Inhibitor or ARB | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1257 | Intolerance to ACE Inhibitor or ARB | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.133 | Beta Blocker Therapy | active | 2023-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1333 | Allergy to Beta Blocker Therapy | active | 2019-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1334 | Intolerance to Beta Blocker Therapy | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1341 | Heart Rate | active | 2024-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1342 | Beta Blocker Therapy for LVSD | active | 2022-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1344 | Acute and Subacute Iridocyclitis | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1353 | Limited Life Expectancy | active | 2025-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1363 | Annual Wellness Visit | active | 2023-12 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1364 | Macular Exam | active | 2021-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1372 | Tobacco Use Screening | active | 2017-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1374 | Bone Scan | active | 2018-07 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1377 | Level of Severity of Retinopathy Findings | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1381 | Macular Edema Findings Present | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1401 | Cognitive Assessment | active | 2017-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1402 | Cup to Disc Ratio | active | 2021-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1403 | Optic Disc Exam for Structural Abnormalities | active | 2021-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1509 | Acute and Subacute Iridocyclitis | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1521 | Burn Confined to Eye and Adnexa | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1523 | Burn Confined to Eye and Adnexa | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1524 | Cataract Secondary to Ocular Disorders | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1526 | Cataract Secondary to Ocular Disorders | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1527 | Cataract Surgery | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1528 | Cataract Surgery | active | 2025-01 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1529 | Cataract Congenital | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1530 | Cataract Congenital | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1532 | Cataract Mature or Hypermature | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1534 | Cataract Mature or Hypermature | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1535 | Cataract Posterior Polar | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1537 | Cataract Posterior Polar | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1538 | Certain Types of Iridocyclitis | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1540 | Certain Types of Iridocyclitis | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1542 | Chronic Iridocyclitis | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1543 | Chronic Iridocyclitis | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1544 | Cloudy Cornea | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1546 | Cloudy Cornea | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1548 | Corneal Edema | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1549 | Corneal Edema | active | 2021-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1550 | Disorders of Cornea Including Corneal Opacity | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1552 | Disorders of Cornea Including Corneal Opacity | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1561 | Glaucoma | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1562 | Glaucoma | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1564 | Hereditary Corneal Dystrophies | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1566 | Hereditary Corneal Dystrophies | active | 2021-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.526.2.1571 | Hypotony of Eye | active | 2025-01 | us | hl7 | sct |